Gemini Surfactant-Based Gene Therapy: Non-Invasive Gene Delivery. Este artículo no está disponible.
Idioma: inglés
Editorial: Lap Lambert Academic Publishing, 2012
- Tapa blanda
- Nuevo
Librería: Revaluation Books, Exeter, Reino UnidoRevaluation Books
Vendedor de 5 estrellas
Vendedor de IberLibro desde 6 de enero de 2003
No disponible
Tapa blanda
Condición: Nuevo
EUR 160,33
Descripción del artículo del vendedor
240 pages. 8.66x5.91x0.55 inches. In Stock.
N° de ref. del artículo __3846581720
- Título
- Gemini Surfactant-Based Gene Therapy: Non-Invasive Gene Delivery
- Autor
- Badea, Ildiko; Foldvari, Marianna; Badea, Ildiko; Foldvari, Marianna
- Editorial
- Lap Lambert Academic Publishing
- Año de publicación
- 2012
- Estado
- Brand New
- Encuadernación
- Paperback
- Idioma
- inglés
- ISBN 10
- 3846581720
- ISBN 13
- 9783846581728
- Peso del artículo
- 0,4 kilogramos
Similar to the majority of biological molecules, DNA is degraded rapidly in the body. Its encapsulation into a delivery system increases circulation time and permits accumulation of the drug in certain organs. Lipid-based soft nanoparticles have the ability to encapsulate or complex DNA and shuttle it into the cells by overcoming cellular and molecular barriers. The use of state-of-the-art technology for the systematic evaluation of the gene transfer efficiency of the novel nanoparticles leads to the development of in vivo gene delivery systems for topical non-invasive administration. These delivery systems find application in the development of new gene therapy for dermatology, immunology/vaccines and neurodegenerative diseases.
“Sinopsis” puede pertenecer a otra edición de este título.
Reseña del editor
Similar to the majority of biological molecules, DNA is degraded rapidly in the body. Its encapsulation into a delivery system increases circulation time and permits accumulation of the drug in certain organs. Lipid-based soft nanoparticles have the ability to encapsulate or complex DNA and shuttle it into the cells by overcoming cellular and molecular barriers. The use of state-of-the-art technology for the systematic evaluation of the gene transfer efficiency of the novel nanoparticles leads to the development of in vivo gene delivery systems for topical non-invasive administration. These delivery systems find application in the development of new gene therapy for dermatology, immunology/vaccines and neurodegenerative diseases.
“Acerca de” puede pertenecer a otra edición de este título.